UCSF is leading a research study to compare the outcomes of radiosurgery versus temporal lobectomy as a treatment for temporal lobe epilepsy. Patients 18 years and older who have seizures that begin in their temporal lobe and are not controlled with medications may be offered entry into the trial. Patients with a high likelihood of having their seizures controlled with open surgery will have treatment randomized between the standard surgery and radiosurgery. The study intends to randomize 234 patients at 14 sites throughout North America.
For additional information on the ROSE study as well as eligibility and exclusion criteria, please contact Nicholas M. Barbaro, M.D., at (415) 353–3557 or email@example.com.
Stem Cell Grants Advance Therapies for Brain Tumors, Diabetes
Two teams of UCSF scientists have received grants from the California Institute for Regenerative Medicine (CIRM) to advance their stem cell-based strategies for treating diabetes and brain tumors.
UCSF Wins Consumer Choice Award for San Francisco Hospitals
UCSF Medical Center has been named the winner of the 2009-2010 Consumer Choice Award for hospitals in San Francisco by the National Research Corporation (NRC), a major health care performance research firm.